Granot N, Storb R
Haematologica. 2020; 105(12):2716-2729.
PMID: 33054108
PMC: 7716373.
DOI: 10.3324/haematol.2019.245688.
Bacigalupo A
Haematologica. 2017; 102(7):1137-1138.
PMID: 28655810
PMC: 5566012.
DOI: 10.3324/haematol.2017.171538.
Mullins G, Greally J, OToole M, Temperley I
Ir J Med Sci. 2016; 145(1):156-62.
PMID: 27517222
DOI: 10.1007/BF02938938.
Gallo S, Woolfrey A, Burroughs L, Storer B, Flowers M, Hari P
Bone Marrow Transplant. 2016; 51(12):1573-1578.
PMID: 27479689
PMC: 5143192.
DOI: 10.1038/bmt.2016.198.
Villa N, Rahman M, McFadden G, Cogle C
Viruses. 2016; 8(3):85.
PMID: 27011200
PMC: 4810275.
DOI: 10.3390/v8030085.
Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
Kumar R, Kimura F, Ahn K, Hu Z, Kuwatsuka Y, Klein J
Biol Blood Marrow Transplant. 2016; 22(5):932-40.
PMID: 26797402
PMC: 4826285.
DOI: 10.1016/j.bbmt.2016.01.012.
Alternative donor transplant of benign primary hematologic disorders.
Tolar J, Sodani P, Symons H
Bone Marrow Transplant. 2015; 50(5):619-27.
PMID: 25665040
PMC: 4424154.
DOI: 10.1038/bmt.2015.1.
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Bacigalupo A, Socie G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M
Haematologica. 2012; 97(8):1142-8.
PMID: 22315497
PMC: 3409810.
DOI: 10.3324/haematol.2011.054841.
Hematopoietic cell transplantation for treatment of primary immune deficiencies.
Burroughs L, Woolfrey A
Cell Ther Transplant. 2010; 2(8).
PMID: 21152385
PMC: 2997756.
DOI: 10.3205/ctt-2010-en-000077.01.
Current and future approaches for control of graft-versus-host disease.
Koreth J, Antin J
Expert Rev Hematol. 2010; 1(1):111.
PMID: 20151032
PMC: 2819425.
DOI: 10.1586/17474086.1.1.111.
HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.
Bonfim C, de Medeiros C, Bitencourt M, Zanis-Neto J, Funke V, Setubal D
Biol Blood Marrow Transplant. 2007; 13(12):1455-60.
PMID: 18022575
PMC: 2174905.
DOI: 10.1016/j.bbmt.2007.08.004.
The HLA system: genetics, immunology, clinical testing, and clinical implications.
Choo S
Yonsei Med J. 2007; 48(1):11-23.
PMID: 17326240
PMC: 2628004.
DOI: 10.3349/ymj.2007.48.1.11.
Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care.
Diaconescu R, Storb R
J Cancer Res Clin Oncol. 2004; 131(1):1-13.
PMID: 15565456
DOI: 10.1007/s00432-004-0611-6.
Hematopoietic stem cell transplantation for severe aplastic anemia--experience of an institute in Taiwan.
Bai L, Chiou T, Liu J, Yen C, Wang W, Yan M
Ann Hematol. 2003; 83(1):38-43.
PMID: 14530878
PMC: 7102357.
DOI: 10.1007/s00277-003-0781-3.
Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children.
Woolfrey A, Pulsipher M, Storb R
Int J Hematol. 2002; 76 Suppl 2:271-7.
PMID: 12430936
DOI: 10.1007/BF03165129.
Stem cell transplantation for aplastic anemia.
Georges G, Storb R
Int J Hematol. 2002; 75(2):141-6.
PMID: 11939259
DOI: 10.1007/BF02982018.
Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.
Horstmann M, Stockschlader M, Kruger W, Hoffknecht M, Betker R, Kabisch H
Ann Hematol. 1995; 71(2):77-81.
PMID: 7654856
DOI: 10.1007/BF01699250.
Alternatives to donor matching for control of graft-versus-host disease.
Vriesendorp H, Klapwijk W, Visser T, Zurcher C, van Bekkum D
Immunogenetics. 1982; 15(1):79-94.
PMID: 7044963
DOI: 10.1007/BF00375505.
Recent developments in allogeneic marrow transplantation for the treatment of severe aplastic anemia.
Storb R
Blut. 1981; 43(6):339-44.
PMID: 7037074
DOI: 10.1007/BF00320311.
[Bone marrow transplantation for aplastic anaemia (author's transl)].
Kolb H, Wundisch G, SPITZER I, Ochsler H, Albert E, Sauer H
Klin Wochenschr. 1981; 59(7):325-42.
PMID: 7017255
DOI: 10.1007/BF01525001.